跳至主要内容
临床试验/IRCT20231226060535N1
IRCT20231226060535N1招募中3 期

Investigating the effect of royal jelly on reducing symptoms of fatigue and weakness associated with chemotherapy in breast cancer

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 60 years(—)
性别
Female

入选标准

  • Confirmed diagnosis of breast cancer by laboratory and clinical evidence
  • Hemoglobin > 8 g/dL
  • Hematocrit > 30%
  • SGOT serum level <3 times higher than normal
  • Bilirubin level less than 2 mg/dl
  • Creatinine less than 2mg/dl
  • Normal thyroid test result

排除标准

  • Having an underlying and chronic active inflammatory disease such as: RA, COPD, unstable cardiovascular disease, lung diseases such as asthma, uncontrolled pain, severe infection, pregnancy, severe depression
  • Simultaneous use of drugs that can affect fatigue
  • Metastatic patients with poor performance

研究者

相似试验